Selected article for: "long term protection and lopinavir ritonavir"
Author: Biswas, Partha; Hasan, Mohammad Mehedi; Dey, Dipta; dos Santos Costa, Ana Carla; Polash, Shakil Ahmed; Bibi, Shabana; Ferdous, Nadim; Kaium, Md. Abu; Rahman, MD. Hasanur; Jeet, Fardin Kamal; Papadakos, Stavros; Islam, Khairul; Uddin, Md. Sahab
Title: Candidate antiviral drugs for COVID-19 and their environmental implications: a comprehensive analysis
  • Cord-id: 78d61iqx
  • Document date: 2021_9_12
    • ID: 78d61iqx
    Snippet: Emerging from Wuhan, China, SARS-CoV-2 is the new global threat that killed millions of people, and many are still suffering. This pandemic has not only affected people but also caused economic crisis throughout the world. Researchers have shown good progress in revealing the molecular insights of SARS-CoV-2 pathogenesis and developing vaccines, but effective treatment against SARS-CoV-2-infected patients are yet to be found. Several vaccines are available and used in many countries, while many
    Document: Emerging from Wuhan, China, SARS-CoV-2 is the new global threat that killed millions of people, and many are still suffering. This pandemic has not only affected people but also caused economic crisis throughout the world. Researchers have shown good progress in revealing the molecular insights of SARS-CoV-2 pathogenesis and developing vaccines, but effective treatment against SARS-CoV-2-infected patients are yet to be found. Several vaccines are available and used in many countries, while many others are still in clinical or preclinical studies. However, this involves a long-term process, considering the safety procedures and requirements and their long-term protection capacity and in different age groups are still questionable. Therefore, at present, the drug repurposing of the existing therapeutics previously designed against other viral diseases seems to be the only practical approach to mitigate the current situation. The safety of most of these therapeutic agents has already been tested. Recent clinical reports revealed promising therapeutic efficiency of several drugs such as remdesivir, tenofovir disoproxil fumarate, azithromycin, lopinavir/ritonavir, chloroquine, baricitinib, and cepharanthine. Besides, plasma therapies were used to treat patients and prevent fatal outcomes. Thus, in this article, we have summarized the epidemiological and clinical data from several clinical trials conducted since the beginning of the pandemic, emphasizing the efficiency of the known agents against SARS-CoV-2 and their harmful side effects on the human body as well as their environmental implications. This review shows a clear overview of the current pharmaceutical perspective on COVID-19 treatment.

    Search related documents:
    Co phrase search for related documents
    • abdominal discomfort and liver damage: 1
    • abdominal discomfort and liver function: 1
    • abdominal discomfort and lupus erythematosus: 1
    • abdominal pain and abnormal stool: 1
    • abdominal pain and acid level: 1
    • abdominal pain and action mechanism: 1
    • abdominal pain and acute renal failure: 1, 2, 3
    • abdominal pain and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • abdominal pain and administration food: 1, 2
    • abdominal pain and adr adverse drug reaction: 1
    • abdominal pain and liver damage: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and lopinavir ritonavir combination: 1